New tool aims to ensure elderly patients get the End-of-Life care they want
NCT ID NCT06002113
First seen Nov 21, 2025 · Last updated Jun 16, 2026 · Updated 32 times
Summary
This study tests a new tool designed to help doctors and elderly patients (80 and older) have better conversations about end-of-life care preferences. The goal is to ensure that treatments like life support match what patients truly want. Researchers will compare the tool to usual care in 1,200 hospitalized patients to see if it improves documentation and reduces unwanted intensive care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END OF LIFE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Royal Victoria Regional Health Centre
RECRUITINGBarrie, Ontario, L4M6M2, Canada
Contact Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.